Long-Term Safety and Efficacy of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study Judge, D., Heitner, S. B., Falk, R. H., Grogan, M., Jacoby, D. L., Maurer, M. S., Selby, V. N., Shah, S. J., Witteles, R., Katz, L., Rao, S., Sinha, U., Fox, J. LIPPINCOTT WILLIAMS & WILKINS. 2019: E966–E967

View details for Web of Science ID 000508228600009